Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BACE1 | P56817 | 4/20 | 0.42 |
| ▸ | CYP26A1 | O43174 | 2/20 | 0.40 |
| ▸ | CYP26B1 | Q9NR63 | 2/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | TSHR | P16473 | 1/20 | 0.38 |
| ▸ | JAK2 | O60674 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8100687 | 0.88 | CYP3A4 (0.47) | BACE1ALDH1A1CYP3A4TSHRJAK2 | |
| SCHEMBL8100983 | 0.86 | RARB (0.44) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8106743 | 0.86 | MEN1 (0.42) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8757257 | 0.85 | RARB (0.40) | BACE1CYP26A1CYP26B1ALDH1A1CYP3A4 | |
| SCHEMBL8748829 | 0.84 | RARB (0.55) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8102431 | 0.83 | RARB (0.43) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8093042 | 0.82 | RORC (0.45) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8093059 | 0.82 | CYP26A1 (0.44) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR | |
| SCHEMBL8561391 | 0.81 | CTSS (0.48) | BACE1CYP3A4 | |
| SCHEMBL8093109 | 0.79 | RARG (0.43) | CYP26A1CYP26B1ALDH1A1CYP3A4TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6051243-A | USEFUL IN THE TOPICAL AND SYSTEMIC TREATMENT OF DERMATOLOGICAL CONDITIONS ASSOCIATED WITH A KERATINIZATION DISORDER, DERMATOLOGICAL CONDITIONS (AND THE LIKE) INCLUDING AN INFLAMMATORY AND/OR IMMUNOALLERGIC COMPONENT | CENTRE INTERNATIONAL DE RECHERCHES DERMATOLOGIQUES (FR) | 2000-04-18 | — | — | US | disclosed |